← All indications
Pulmonary Valve Insufficiency
Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.
Drugs by status
Phase 4 trials (1)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (39)
- Bayer
- Mallinckrodt
- National Center for Research Resources (NCRR)
- Baylor University
- Brown University
- Case Western Reserve University
- Emory University
- University of Washington
- Indiana University
- Katholieke Universiteit Leuven
- McGill University
- McMaster University
- Stanford University
- Thomas Jefferson University
- University of Miami
- University of New Mexico
- University of Ottawa
- University of Saskatchewan
- University of Sydney
- University of Tennessee
- University of Bordeaux
- Wayne State University
- Yale University
- University of British Columbia
- University of Calgary
- University of California, San Diego
- University of Cincinnati
- University of Amsterdam
- University of Wisconsin
- University of Alabama, Birmingham
- +9 more
Organization Involved with Phase 2 Indications (20)
- Theravance
- Mylan
- PhaseBio Pharmaceuticals Inc.
- National Institutes of Health (NIH)
- National Polytechnic Institute, Mexico
- Aarhus University
- Duke University
- Ohio State University
- RTI International
- Tufts University
- University of Iowa
- University of Rochester
- University of Southern Denmark
- Aalborg University
- University of California, Los Angeles
- University of Copenhagen
- University of Utah
- Universita' Cattolica del Sacro Cuore
- Hospital Agostino Gemelli
- Hospital Regional de Alta Especialidad de Zumpango
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (6)